Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	277.56	91.32	-24.19
Graham Fair Price	-66.58	1.38	4.12
PEG	33856.10	-0.12	< 0.005
Price/Book	-1.64	0.76	0.77
Price/Cash Flow	-19.04	-6.21	7.67
Prices/Earnings	1712.75	13.01	-0.72
Price/Sales	44.29	1.09	0.75
Price/FCF	-19.04	-6.21	7.67
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	58.72	0.09	0.06
Operating Margin	-91.15	0.03	-0.29
ROA	-94.49	< 0.005	-0.05
ROE	-0.27	0.01	-94.57
ROIC	-0.11	< 0.005	-94.20
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.15	-0.11	-42.00
Dividends QOQ	-0.54	-0.27	50.25
EBIT QOQ	-33.86	1.06	-96.87
EPS QOQ	-19.52	1.04	-94.66
FCF QOQ	-0.19	-2.23	-1068.17
Revenue QOQ	0.31	-0.31	0.42
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	29.54	44.53	50.74
Days Sales Outstanding (DSO)	280.54	413.25	47.31
Inventory Turnover	3.05	2.02	-33.66
Debt/Capitalization	0.65	0.60	-6.40
Quick Ratio	0.99	0.99	0.22
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.67	2.40	43.49
Cash	0.96	1.40	45.09
Capex	< 0.005	< 0.005	-413.50
Free Cash Flow	0.17	-0.29	74.34
Revenue	1.72	1.68	-2.19
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.20	1.18	-1.70
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-15.37	50.64	229.45
Naive Interpretation	Member

06 - Financial Health · Bad

Rating